FujianHuaxiaSyntheticLeatherCo.,Ltd.,establishedin2005,islocatedinLonganIndustrialZone,Fuding,Fujian.

更新时间：2024-09-22 直链：www.fujianhuaxialeather.com

探索生物仪器设备,尤维斯专业代理：SONICS超声波均质机,SONICS超声波连续流破碎仪,SONICS超声波处理器,并获得相关设备的服务支持。

更新时间：2023-11-28 直链：www.proteinpowdernt.com

更新时间：2023-06-04 直链：www.ourproteinfactory.com

湖北普罗金科技有限公司

更新时间：2023-11-28 直链：www.proteingene.com

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

更新时间：2023-11-28 直链：westvacpharma.com

Klyomocompanylimited-Klyomocompanylimited,cansupplyFoodIngredient,FeedIngredient,API,IndustryProducts.

更新时间：2023-11-28 直链：www.klyomo.com

谱天（天津）生物科技有限公司聚焦精准医学最前沿多组学领域的国家高新技术企业。天津市临床多组学重点实验室牵头单位，率先开展基因+蛋白+代谢的多组学研究，其中自主知识产权的蛋白质谱液体活检技术水平居于国际前列。核心团队来自耶鲁大学、美国国立卫生研究院、国家蛋白质科学中心等国内外知名科研院所。公司研发管线涵盖肝癌、肺癌、胃癌、食道癌、结直肠癌、胰腺癌等常见癌种和泛癌种及心脑血管等疾病的早筛早诊、复发监测、伴随诊断等。具有核心知识产权的UmbrellaTM 临床分子数据库，临床样本数据10W+,谱天致力于不断创新医学技术及其商业化与临床应用，推动医学发展，探寻人类健康的更多可能。

更新时间：2023-05-10 直链：www.proteint.com